Comput. Biol. Med. - Prediction of the mode of interaction between monoterpenes and the nitroreductase from Enterobacter cloacae by docking simulation.

Tópicos

{ method(1557) propos(1049) approach(1037) }
{ drug(1928) target(777) effect(648) }
{ bind(1733) structur(1185) ligand(1036) }
{ activ(1452) weight(1219) physic(1104) }
{ imag(2830) propos(1344) filter(1198) }
{ chang(1828) time(1643) increas(1301) }
{ cost(1906) reduc(1198) effect(832) }
{ model(3404) distribut(989) bayesian(671) }
{ network(2748) neural(1063) input(814) }
{ error(1145) method(1030) estim(1020) }
{ design(1359) user(1324) use(1319) }
{ model(2220) cell(1177) simul(1124) }
{ care(1570) inform(1187) nurs(1089) }
{ visual(1396) interact(850) tool(830) }
{ patient(2837) hospit(1953) medic(668) }
{ gene(2352) biolog(1181) express(1162) }
{ activ(1138) subject(705) human(624) }
{ use(2086) technolog(871) perceiv(783) }
{ method(1969) cluster(1462) data(1082) }
{ can(774) often(719) complex(702) }
{ imag(1947) propos(1133) code(1026) }
{ data(1737) use(1416) pattern(1282) }
{ inform(2794) health(2639) internet(1427) }
{ system(1976) rule(880) can(841) }
{ measur(2081) correl(1212) valu(896) }
{ imag(1057) registr(996) error(939) }
{ sequenc(1873) structur(1644) protein(1328) }
{ method(1219) similar(1157) match(930) }
{ featur(3375) classif(2383) classifi(1994) }
{ imag(2675) segment(2577) method(1081) }
{ patient(2315) diseas(1263) diabet(1191) }
{ take(945) account(800) differ(722) }
{ studi(2440) review(1878) systemat(933) }
{ motion(1329) object(1292) video(1091) }
{ assess(1506) score(1403) qualiti(1306) }
{ treatment(1704) effect(941) patient(846) }
{ surgeri(1148) surgic(1085) robot(1054) }
{ framework(1458) process(801) describ(734) }
{ problem(2511) optim(1539) algorithm(950) }
{ learn(2355) train(1041) set(1003) }
{ concept(1167) ontolog(924) domain(897) }
{ clinic(1479) use(1117) guidelin(835) }
{ algorithm(1844) comput(1787) effici(935) }
{ extract(1171) text(1153) clinic(932) }
{ data(1714) softwar(1251) tool(1186) }
{ control(1307) perform(991) simul(935) }
{ general(901) number(790) one(736) }
{ method(984) reconstruct(947) comput(926) }
{ search(2224) databas(1162) retriev(909) }
{ featur(1941) imag(1645) propos(1176) }
{ case(1353) use(1143) diagnosi(1136) }
{ howev(809) still(633) remain(590) }
{ data(3963) clinic(1234) research(1004) }
{ studi(1410) differ(1259) use(1210) }
{ risk(3053) factor(974) diseas(938) }
{ perform(999) metric(946) measur(919) }
{ research(1085) discuss(1038) issu(1018) }
{ system(1050) medic(1026) inform(1018) }
{ import(1318) role(1303) understand(862) }
{ model(2341) predict(2261) use(1141) }
{ compound(1573) activ(1297) structur(1058) }
{ perform(1367) use(1326) method(1137) }
{ studi(1119) effect(1106) posit(819) }
{ blood(1257) pressur(1144) flow(957) }
{ spatial(1525) area(1432) region(1030) }
{ record(1888) medic(1808) patient(1693) }
{ health(3367) inform(1360) care(1135) }
{ model(3480) simul(1196) paramet(876) }
{ monitor(1329) mobil(1314) devic(1160) }
{ ehr(2073) health(1662) electron(1139) }
{ state(1844) use(1261) util(961) }
{ research(1218) medic(880) student(794) }
{ model(2656) set(1616) predict(1553) }
{ data(2317) use(1299) case(1017) }
{ age(1611) year(1155) adult(843) }
{ medic(1828) order(1363) alert(1069) }
{ signal(2180) analysi(812) frequenc(800) }
{ group(2977) signific(1463) compar(1072) }
{ sampl(1606) size(1419) use(1276) }
{ data(3008) multipl(1320) sourc(1022) }
{ first(2504) two(1366) second(1323) }
{ intervent(3218) particip(2042) group(1664) }
{ time(1939) patient(1703) rate(768) }
{ patient(1821) servic(1111) care(1106) }
{ can(981) present(881) function(850) }
{ analysi(2126) use(1163) compon(1037) }
{ health(1844) social(1437) communiti(874) }
{ structur(1116) can(940) graph(676) }
{ high(1669) rate(1365) level(1280) }
{ cancer(2502) breast(956) screen(824) }
{ use(976) code(926) identifi(902) }
{ use(1733) differ(960) four(931) }
{ result(1111) use(1088) new(759) }
{ implement(1333) system(1263) develop(1122) }
{ survey(1388) particip(1329) question(1065) }
{ estim(2440) model(1874) function(577) }
{ decis(3086) make(1611) patient(1517) }
{ process(1125) use(805) approach(778) }
{ method(2212) result(1239) propos(1039) }
{ detect(2391) sensit(1101) algorithm(908) }

Resumo

Monoterpenes from the essential oils of several plants have been shown to enhance the bactericidal activities of nitrofurantoin and furazolidone against the bacteria of Enterobacteriaceae family. In this study, computer-aided molecular modeling and docking techniques have been employed to simulate the theoretical mode of interaction between monoterpenes and Enterobacter cloacae nitroreductase. Enhancement of nitro drug potency in the presence of monoterpenes may be the result of modulation of nitroreductase activity. Binding nitroreductase with monoterpenes may decrease the efficient conversion of toxic reactive intermediates to final products lacking bactericidal activity.

Resumo Limpo

monoterpen essenti oil sever plant shown enhanc bactericid activ nitrofurantoin furazolidon bacteria enterobacteriacea famili studi computeraid molecular model dock techniqu employ simul theoret mode interact monoterpen enterobact cloaca nitroreductas enhanc nitro drug potenc presenc monoterpen may result modul nitroreductas activ bind nitroreductas monoterpen may decreas effici convers toxic reactiv intermedi final product lack bactericid activ

Resumos Similares

J Chem Inf Model - Predicting drug-target interactions using probabilistic matrix factorization. ( 0,659594904415405 )
J Chem Inf Model - Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches. ( 0,633511719957631 )
J Chem Inf Model - Structural modeling of HCV NS3/4A serine protease drug-resistance mutations using end-point continuum solvation and side-chain flexibility calculations. ( 0,63260613369564 )
Comput. Biol. Med. - Revealing pharmacodynamics of medicinal plants using in silico approach: a case study with wet lab validation. ( 0,614839115496939 )
Comput Math Methods Med - A modified amino acid network model contains similar and dissimilar weight. ( 0,608953397551453 )
J Chem Inf Model - Key amino acid associated with acephate detoxification by Cydia pomonella carboxylesterase based on molecular dynamics with alanine scanning and site-directed mutagenesis. ( 0,607422843576034 )
J. Comput. Biol. - Analysis of metabolic evolution in bacteria using whole-genome metabolic models. ( 0,598632750656797 )
Wiley Interdiscip Rev Syst Biol Med - Systems biology-embedded target validation: improving efficacy in drug discovery. ( 0,587615576937685 )
J Chem Inf Model - Characterizing binding of small molecules. II. Evaluating the potency of small molecules to combat resistance based on docking structures. ( 0,583298172225104 )
J Chem Inf Model - Molecular basis of drug resistance in A/H1N1 virus. ( 0,582581939521228 )
J Chem Inf Model - Drug effect prediction by polypharmacology-based interaction profiling. ( 0,576588288169344 )
J Chem Inf Model - Computational prediction of structure-activity relationships for the binding of aminocyclitols to ?-glucocerebrosidase. ( 0,575753485458511 )
J Chem Inf Model - Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies. ( 0,574303598336798 )
Comput Biol Chem - Detecting breakdown points in metabolic networks. ( 0,573317741454721 )
J Chem Inf Model - Efficient a priori identification of drug resistant mutations using Dead-End Elimination and MM-PBSA. ( 0,570154862841052 )
J Chem Inf Model - A computational approach to design and evaluate enzymatic reaction pathways: application to 1-butanol production from pyruvate. ( 0,55861318451258 )
J Chem Inf Model - Conformational determinants of the activity of antiproliferative factor glycopeptide. ( 0,555529679562992 )
J Chem Inf Model - Elucidating substrate promiscuity in the human cytochrome 3A4. ( 0,553012910915054 )
J Chem Inf Model - Computational modeling of an epidermal growth factor receptor single-mutation resistance to cetuximab in colorectal cancer treatment. ( 0,552176284033142 )
J Chem Inf Model - Anisotropic solvent model of the lipid bilayer. 2. Energetics of insertion of small molecules, peptides, and proteins in membranes. ( 0,551869079348158 )
J Chem Inf Model - Network-based analysis and characterization of adverse drug-drug interactions. ( 0,549292941675835 )
J Chem Inf Model - A Refined Model of the HCV NS5A protein bound to daclatasvir explains drug-resistant mutations and activity against divergent genotypes. ( 0,547845465644447 )
Methods Inf Med - Exploiting online discussions to discover unrecognized drug side effects. ( 0,541233787048202 )
J Chem Inf Model - Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis. ( 0,540758414160568 )
J Chem Inf Model - Long-range effects of a peripheral mutation on the enzymatic activity of cytochrome P450 1A2. ( 0,538148380383665 )
J Chem Inf Model - Understanding product specificity of protein lysine methyltransferases from QM/MM molecular dynamics and free energy simulations: the effects of mutation on SET7/9 beyond the Tyr/Phe switch. ( 0,537079545360463 )
J Chem Inf Model - Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. ( 0,536718653548498 )
J Chem Inf Model - Detailed mechanism of squalene epoxidase inhibition by terbinafine. ( 0,535387665393119 )
J Chem Inf Model - Extracting sets of chemical substructures and protein domains governing drug-target interactions. ( 0,534368195595454 )
J. Comput. Biol. - Exploring the landscape of protein-ligand interaction energy using probabilistic approach. ( 0,532991275855519 )
J Chem Inf Model - Impact of resistance mutations on inhibitor binding to HIV-1 integrase. ( 0,530864216930108 )
J Chem Inf Model - HotLig: a molecular surface-directed approach to scoring protein-ligand interactions. ( 0,527506112283224 )
J Chem Inf Model - Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization. ( 0,526469830649863 )
J Chem Inf Model - Free energy calculations give insight into the stereoselective hydroxylation of a-ionones by engineered cytochrome P450 BM3 mutants. ( 0,52549320206012 )
J Chem Inf Model - How does catalase release nitric oxide? A computational structure-activity relationship study. ( 0,520918125085354 )
J Chem Inf Model - Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid. ( 0,520046228386098 )
J Chem Inf Model - Identification of the Schistosoma mansoni molecular target for the antimalarial drug artemether. ( 0,518343944838785 )
J. Comput. Biol. - A genome-scale modeling approach to study inborn errors of liver metabolism: toward an in silico patient. ( 0,517493215220478 )
Int J Neural Syst - Efficacy of a new charge-balanced biphasic electrical stimulus in the isolated sciatic nerve and the hippocampal slice. ( 0,517342828965441 )
Comput. Biol. Med. - Just an additional hydrogen bond can dramatically reduce the catalytic activity of Bacillus subtilis lipase A I12T mutant: an integration of computational modeling and experimental analysis. ( 0,514386879843215 )
J Chem Inf Model - Unbinding pathways of GW4064 from human farnesoid X receptor as revealed by molecular dynamics simulations. ( 0,514228276461994 )
J Chem Inf Model - Computational prediction of a putative binding site on drp1: implications for antiparkinsonian therapy. ( 0,513378969047815 )
J Biomed Inform - A comparison of machine learning techniques for detection of drug target articles. ( 0,513054966561778 )
J. Comput. Biol. - Protein-specific scoring method for ligand discovery. ( 0,51220431699983 )
J Biomed Inform - Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data. ( 0,512180319214133 )
Wiley Interdiscip Rev Syst Biol Med - Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. ( 0,511346102855856 )
J Chem Inf Model - Pharmacophore modeling, virtual screening, and in vitro testing reveal haloperidol, eprazinone, and fenbutrazate as neurokinin receptors ligands. ( 0,507852219823771 )
J Chem Inf Model - Potency prediction of ?-secretase (BACE-1) inhibitors using density functional methods. ( 0,507346289431841 )
Comput. Biol. Med. - Mathematica program: its use to simulate metabolic irreversible pathways and inhibition of the first enzyme of a pathway by its end product as visualized with the reservoir model. ( 0,50727482717507 )
Neural Comput - A finite-sample, distribution-free, probabilistic lower bound on mutual information. ( 0,505113606171676 )
J Chem Inf Model - Comparison and druggability prediction of protein-ligand binding sites from pharmacophore-annotated cavity shapes. ( 0,504662394066316 )
Comput Biol Chem - Robust classifying of prokaryotic genomes. ( 0,50451894819764 )
J Chem Inf Model - Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy. ( 0,504376805798292 )
J Chem Inf Model - Structural basis for the ?-adrenergic receptor subtype selectivity of the representative agonists and antagonists. ( 0,503319774680388 )
Comput. Biol. Med. - Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development. ( 0,501515740392712 )
Wiley Interdiscip Rev Syst Biol Med - Developing melanoma therapeutics: overview and update. ( 0,500850967881827 )
J Chem Inf Model - Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. ( 0,500706468590231 )
J Chem Inf Model - Contribution of 2D and 3D structural features of drug molecules in the prediction of Drug Profile Matching. ( 0,500389085707605 )
J Chem Inf Model - Automated ligand- and structure-based protocol for in silico prediction of human serum albumin binding. ( 0,499800841767528 )
J Chem Inf Model - Residue preference mapping of ligand fragments in the Protein Data Bank. ( 0,497867151698677 )
J Chem Inf Model - Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations. ( 0,496399143617516 )
J Chem Inf Model - Structurally conserved binding sites of hemagglutinin as targets for influenza drug and vaccine development. ( 0,495760099456238 )
Comput Math Methods Med - Antibody Drug Conjugate bioinformatics: drug delivery through the letterbox. ( 0,495467236356604 )
J Chem Inf Model - Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculations. ( 0,495343517077446 )
J. Med. Internet Res. - Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries. ( 0,49435058318062 )
Comput Math Methods Med - Information analysis on neural tuning in dorsal premotor cortex for reaching and grasping. ( 0,49391748379318 )
J Chem Inf Model - Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics. ( 0,493511802013197 )
J Chem Inf Model - A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation. ( 0,493453768474435 )
Comput Biol Chem - Pharmacokinetic analysis of multi PEG-theophylline conjugates. ( 0,491711293908394 )
J Chem Inf Model - Functional motions modulating VanA ligand binding unraveled by self-organizing maps. ( 0,491514265226781 )
J Am Med Inform Assoc - Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. ( 0,491253687627171 )
J Chem Inf Model - 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes. ( 0,491011117378301 )
J Chem Inf Model - Pathway analysis for drug repositioning based on public database mining. ( 0,490869241045545 )
J Chem Inf Model - Insights into the conformational switching mechanism of the human vascular endothelial growth factor receptor type 2 kinase domain. ( 0,490463656973762 )
Comput. Biol. Med. - Comprehension of drug toxicity: software and databases. ( 0,490162973162743 )
J Chem Inf Model - Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors. ( 0,48891329089864 )
Comput Math Methods Med - Implication of crystal water molecules in inhibitor binding at ALR2 active site. ( 0,488791763067464 )
Comput. Biol. Med. - Dynamic thermal imaging analysis in the effectiveness evaluation of warming and cooling formulations. ( 0,486660800218249 )
J Chem Inf Model - Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding. ( 0,485767965154677 )
J Chem Inf Model - Molecular principle of topotecan resistance by topoisomerase I mutations through molecular modeling approaches. ( 0,48572392856353 )
Wiley Interdiscip Rev Syst Biol Med - Drug repurposing and adverse event prediction using high-throughput literature analysis. ( 0,485590426401877 )
Med Biol Eng Comput - Automated segmentation of comet assay images using Gaussian filtering and fuzzy clustering. ( 0,484063684843552 )
J Chem Inf Model - Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome. ( 0,483994959528567 )
J Biomed Inform - Exploring the associations between drug side-effects and therapeutic indications. ( 0,483951258858484 )
J Chem Inf Model - A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling. ( 0,483768317062602 )
J Chem Inf Model - Effect of structural stress on the flexibility and adaptability of HIV-1 protease. ( 0,483232359754097 )
J Chem Inf Model - Molecular dynamics simulations of a hyperthermophilic and a mesophilic protein L30e. ( 0,482697810519955 )
J Chem Inf Model - How important is the synclinal conformation of sulfonylureas to explain the inhibition of AHAS: a theoretical study. ( 0,480884601541784 )
J Chem Inf Model - Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps. ( 0,478896569946124 )
J Chem Inf Model - Visually interpretable models of kinase selectivity related features derived from field-based proteochemometrics. ( 0,478449390719496 )
J Biomed Inform - Combining automatic table classification and relationship extraction in extracting anticancer drug-side effect pairs from full-text articles. ( 0,477188288784679 )
Comput Math Methods Med - The height gain in scoliotic deformity correction: assessed by new predictive formula. ( 0,476287518858402 )
AMIA Annu Symp Proc - Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity. ( 0,476150592759003 )
J Biomed Inform - Using semantic predications to uncover drug-drug interactions in clinical data. ( 0,475403429184921 )
J Chem Inf Model - Combining dyad protonation and active site plasticity in BACE-1 structure-based drug design. ( 0,475341102208891 )
J Chem Inf Model - Interactions of halichondrin B and eribulin with tubulin. ( 0,474266347196187 )
J Chem Inf Model - ReactionPredictor: prediction of complex chemical reactions at the mechanistic level using machine learning. ( 0,473628888819426 )
J. Comput. Biol. - A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study. ( 0,472942296629689 )
AMIA Annu Symp Proc - Exploring the relationship between drug side-effects and therapeutic indications. ( 0,472288858536598 )
J. Comput. Biol. - Discovery of protein complexes with core-attachment structures from Tandem Affinity Purification (TAP) data. ( 0,472235690010391 )